Generalized Pustular Psoriasis: A Consensus Statement from the National Psoriasis Foundation

By sjmartinez • October 15, 2023

Armstrong AW, Elston CA, Elewski BE, Ferris LK, Gottlieb AB, Lebwohl MG; Medical Board of the National Psoriasis Foundation.. Generalized Pustular Psoriasis: A Consensus Statement from the National Psoriasis Foundation. J Am Acad Dermatol. 2023 Oct 12:S0190-9622(23)02969-9. doi: 10.1016/j.jaad.2023.09.080. Epub ahead of print. PMID: 37838256.

Tags: access, consensus statement, Dermatology, generalized pustular psoriasis, IL-36 inhibition, imsidolimab, national psoriasis foundation, psoriasis, Publications, spesolimab, therapy, Treatment

Inhibition of pyruvate oxidation diminishes melanoma progression

Seyran B, Avila I, Galvan C, Robles G, Murphy C, Christofk H, Lowry WE. Inhibition of pyruvate oxidation diminishes melanoma progression. J Invest Dermatol. 2024[...]

Low-Dose Oral Minoxidil Initiation for Patients With Hair Loss: An International Modified Delphi Consensus Statement

Akiska YM, Mirmirani P, Roseborough I, Mathes E, Bhutani T, Ambrosy A, Aguh C, Bergfeld W, Callender VD, Castelo-Soccio L, Cotsarelis G, Craiglow BG, Desai[...]

Mart-1 During Mohs Micrographic Surgery for Melanoma Excision Results in Decreased Stage Number and Decreased Frequency of Secondary Pathologic Consultation

Zhang R, Yueh K, Anderson M, Bennett RG. Mart-1 During Mohs Micrographic Surgery for Melanoma Excision Results in Decreased Stage Number and Decreased Frequency of[...]